文献速递胸部CTPET

个体化列线图预测肺腺癌患者ALK重排状态

Individualized nomogram for predicting ALK rearrangement status in lung adenocarcinoma patients.
PubMed 文献 · Eur Radiol · 2020-11-04

本研究回顾性纳入399例肺腺癌患者(ALK重排129例、ALK阴性270例),按4:1随机分为训练队列与内部验证队列,整合临床、CT、PET/CT及组织病理特征构建逻辑回归模型并建立列线图。整合模型训练队列AUC为0.918(95%CI 0.886-0.950),验证队列AUC为0.857(95%CI 0.777-0.937),显示组织病理特征可为基于影像特征的模型增加价值。

要点

  • 年轻、从不吸烟、淋巴结增大、空洞、高SUVmax、实性或微乳头为主亚型及局部侵犯为ALK重排的独立预测因素。
  • 整合模型训练队列敏感度0.774、特异度0.934;验证队列敏感度0.739、特异度0.810。
  • 贴壁为主型且TTF-1阴性的肺腺癌不太可能伴有ALK重排。

核心结论

  • 整合临床、影像及组织病理特征的列线图可作为无创辅助工具评估肺腺癌ALK重排概率。
  • 组织病理特征为基于影像特征的模型增加了预测价值。

研究设计与样本

  • 回顾性研究,纳入399例肺腺癌患者,其中ALK重排129例、ALK阴性270例。
  • 按4:1比例随机分为训练队列和内部验证队列。
  • 使用临床因素、放射科医师定义的CT特征、SUVmax及组织病理特征,通过逐步后退法多变量逻辑回归构建预测模型。
  • 采用AUC评价模型,并用DeLong检验比较整合模型与临床-影像模型。

关键影像表现/征象

  • 淋巴结增大、空洞、高SUVmax、实性或微乳头为主组织学亚型及局部侵犯与ALK重排相关。

诊断标准与关键数值

  • 整合模型训练队列AUC 0.918(95%CI 0.886-0.950),敏感度0.774,特异度0.934。
  • 整合模型验证队列AUC 0.857(95%CI 0.777-0.937),敏感度0.739,特异度0.810。

临床应用与阅片要点

  • 列线图可计算肺腺癌患者携带ALK突变的概率,作为补充性无创工具。
  • 病理分析对预测肺腺癌ALK重排很重要。
  • 贴壁为主生长模式且TTF-1阴性的肺腺癌不太可能伴有ALK重排。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop a nomogram to identify anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma patients using clinical, CT, PET/CT, and histopathological features.

METHODS: This retrospective study included 399 lung adenocarcinoma patients (129 ALK-rearranged patients and 270 ALK-negative patients) that were randomly divided into a training cohort and an internal validation cohort (4:1 ratio). Clinical factors, radiologist-defined CT features, maximum standard uptake values (SUVmax), and histopathological features were used to construct predictive models with stepwise backward-selection multivariate logistic regression (MLR). The models were then evaluated using the AUC. The integrated model was compared to the clinico-radiological model using the DeLong test to evaluate the role of histopathological features. An associated individualized nomogram was established.

RESULTS: The integrated model reached an AUC of 0.918 (95% CI, 0.886-0.950), sensitivity of 0.774, and specificity of 0.934 in the training cohort and an AUC of 0.857 (95% CI, 0.777-0.937), sensitivity of 0.739, and specificity of 0.810 in the validation cohort. The MLR analysis showed that younger age, never smoker, lymph node enlargement, the presence of cavity, high SUVmax, solid or micropapillary predominant histology subtype, and local invasiveness were strong and independent predictors of ALK rearrangements. The nomogram calculated the risk of harboring ALK mutation for lung adenocarcinoma patients and exhibited a good generalization ability.

CONCLUSION: Our study demonstrates that histopathological features added value to the imaging characteristics-based model. The nomogram with clinical, imaging, and histopathological features can serve as a supplementary non-invasive tool to evaluate the probability of ALK rearrangement in lung adenocarcinoma.

KEY POINTS: • The developed nomogram can accurately predict the probability of lung adenocarcinoma harboring ALK-fused gene. • Pathological analysis is important to predict ALK rearrangement in lung adenocarcinoma. • Lung adenocarcinoma with lepidic predominant growth pattern and TTF-1 negativity is unlikely to have ALK rearrangement.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Song L, Zhu Z, Wu H, et al. Individualized nomogram for predicting ALK rearrangement status in lung adenocarcinoma patients. Eur Radiol. 2020. PMID: 33146791. doi:10.1007/s00330-020-07331-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。